Tan DS - Search Results

1

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.

Tan DS, Marchió C, Jones RL, Savage K, Smith IE, Dowsett M, Reis-Filho JS. Tan DS, et al. Breast Cancer Res Treat. 2008 Sep;111(1):27-44. doi: 10.1007/s10549-007-9756-8. Epub 2007 Oct 6. Breast Cancer Res Treat. 2008. PMID: 17922188

2

Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.

Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis-Filho JS. Arriola E, et al. Among authors: tan ds. Lab Invest. 2007 Jan;87(1):75-83. doi: 10.1038/labinvest.3700495. Lab Invest. 2007. PMID: 17170740 Free article.

3

Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research.

Tan DS, Lambros MB, Natrajan R, Reis-Filho JS. Tan DS, et al. Lab Invest. 2007 Aug;87(8):737-54. doi: 10.1038/labinvest.3700593. Epub 2007 Jun 11. Lab Invest. 2007. PMID: 17558419 Free article. Review.

4

Are triple-negative tumours and basal-like breast cancer synonymous?

Rakha EA, Tan DS, Foulkes WD, Ellis IO, Tutt A, Nielsen TO, Reis-Filho JS. Rakha EA, et al. Among authors: tan ds. Breast Cancer Res. 2007;9(6):404; author reply 405. doi: 10.1186/bcr1827. Breast Cancer Res. 2007. PMID: 18279542 Free PMC article. No abstract available.

5

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS. Arriola E, et al. Among authors: tan ds. Lab Invest. 2008 May;88(5):491-503. doi: 10.1038/labinvest.2008.19. Epub 2008 Mar 10. Lab Invest. 2008. PMID: 18332872 Free article.

6

Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.

Tan DS, Reis-Filho JS. Tan DS, et al. Pathobiology. 2008;75(2):63-74. doi: 10.1159/000123844. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544961 Free article. Review.

7

Hereditary breast cancer: from molecular pathology to tailored therapies.

Tan DS, Marchiò C, Reis-Filho JS. Tan DS, et al. J Clin Pathol. 2008 Oct;61(10):1073-82. doi: 10.1136/jcp.2008.057950. Epub 2008 Aug 4. J Clin Pathol. 2008. PMID: 18682420 Review.

8

Development of therapeutic approaches to 'triple negative' phenotype breast cancer.

Shiu KK, Tan DS, Reis-Filho JS. Shiu KK, et al. Among authors: tan ds. Expert Opin Ther Targets. 2008 Sep;12(9):1123-37. doi: 10.1517/14728222.12.9.1123. Expert Opin Ther Targets. 2008. PMID: 18694379 Review.

9

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

Tan DS, Lambros MB, Marchiò C, Reis-Filho JS. Tan DS, et al. J Pathol. 2008 Nov;216(3):271-4. doi: 10.1002/path.2432. J Pathol. 2008. PMID: 18788074

10

The genomic profile of HER2-amplified breast cancers: the influence of ER status.

Marchiò C, Natrajan R, Shiu KK, Lambros MB, Rodriguez-Pinilla SM, Tan DS, Lord CJ, Hungermann D, Fenwick K, Tamber N, Mackay A, Palacios J, Sapino A, Buerger H, Ashworth A, Reis-Filho JS. Marchiò C, et al. Among authors: tan ds. J Pathol. 2008 Dec;216(4):399-407. doi: 10.1002/path.2423. J Pathol. 2008. PMID: 18810758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page